Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 26.5% in 2021. ▼ Falling
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (excluding high income), 2000–2021
Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.
Analysis
In 2021, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income) stood at 26.5%. That is the lowest value across all 22 years on record.
Compared with earlier readings it is down 5.9% on the previous year and down 20.2% over ten years.
Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income) peaked at 40.0% in 2000 and was at its lowest, 26.5%, in 2021.
Europe & Central Asia (excluding high income) ranks 3rd of 47 groups on this measure, in the top 10%.
The long-run direction has been consistently falling across the 22 years of available data.
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (excluding high income), year by year
| Year | % | Change |
|---|---|---|
| 2000 | 40.0% | — |
| 2001 | 38.8% | -2.9% |
| 2002 | 38.8% | -0.0% |
| 2003 | 38.5% | -0.7% |
| 2004 | 38.1% | -1.0% |
| 2005 | 38.6% | +1.3% |
| 2006 | 37.5% | -2.8% |
| 2007 | 37.0% | -1.6% |
| 2008 | 36.2% | -1.9% |
| 2009 | 35.0% | -3.4% |
| 2010 | 34.2% | -2.4% |
| 2011 | 33.2% | -2.8% |
| 2012 | 32.5% | -2.0% |
| 2013 | 31.5% | -3.1% |
| 2014 | 31.5% | -0.1% |
| 2015 | 30.5% | -3.1% |
| 2016 | 30.1% | -1.5% |
| 2017 | 29.4% | -2.2% |
| 2018 | 29.2% | -0.5% |
| 2019 | 28.7% | -1.9% |
| 2020 | 28.2% | -1.9% |
| 2021 | 26.5% | -5.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 37.9% | 35.0% | 40.0% | 10 |
| 2010s | 31.1% | 28.7% | 34.2% | 10 |
| 2020s | 27.3% | 26.5% | 28.2% | 2 |
Countries ranked near Europe & Central Asia (excluding high income)
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income)?
- Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income) was 26.5% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
- What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 40.0% in 2000.
- What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 26.5% in 2021.
- How does Europe & Central Asia (excluding high income) rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Europe & Central Asia (excluding high income) ranks 3rd out of 47 groups with data for 2021.
- Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is down 20.2%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).